AV node ablation: new aspects in the time of curative therapy of atrial fibrillation and cardiac resynchronization therapy
Authors:
M. Táborský; P. Neužil
Authors‘ workplace:
Kardiologické oddělení Nemocnice Na Homolce, Praha
Published in:
Kardiol Rev Int Med 2006, 8(Supplementum): 10-12
Overview
Several series have reported on positive effect of AV nodal ablation and pacemaker implant in patients with atrial fibrillation resistant to drug therapy. However, right ventricular apical single-site pacing increases a risk of worsening of cardiac performance in those with advanced heart failure, atrial fibrillation (AF) and antioventricular block. Biventricular pacing appears to enhance both systolic function and quality of life in this cohort of subjects.
Keywords:
atrial fibrillation - AV nodal ablation - cardiac resynchronization therapy
Sources
1. Kannel WB, Wolf PA, Benjamin EJ, Lewy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: Population-based estimates. Am J Cardiol 1998; 82(8A): 2-9.
2. The CONCENSUS trial study group. Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med 1987; 316: 1429-35.
3. Johnstone D, Limacher M, Rousseau M et al. Clinical characteristics of patients in studies of left ventricular dysfunction (SOLVD). Am J Cardiol 1992; 70(9): 894-900.
4. Crijns HJCG, Tjeerdsma G, deKam PJ et al. Prognostic value of presence and development of atrial fibrillation in patients with advanced chronic heart failure. Eur Heart J 2000; 21(15): 1238-45.
5. Wyse DG, Love JC, Tao O et al. Atrial fibrillation: a risk factor for increased mortality- an AVID registry analysis. J Interv Card Electrophysiol 2001; 5(3): 267-73.
6. Convert G, Delaye J, Beaune J et al. Prognosis of primary non-obstructive cardiomyopathies. Arch Mal Coeur Vaiss 1980; 73(3): 227-37.
7. Bernstein AD, Parsonnet V. Survey of cardiac pacing and defibrillation in the United States in 1995. Am J Cardiol 1996; 78: 178-196.
8. Fiala M. Doporučené postupy pro diagnostiku a léčbu supraventrikulárních tachyarytmií. Cor Vasa 2005; 47, 9: 18-39.
9. Wood MA, Brown-Mahoney C, Kay GN et al. Clinical outcomes after ablation and pacing therapy for atrial fibrillation: a meta-analysis. Circulation 2000; 101: 1138-44.
10. Rosenquist M, Brandt J, Schuller H. Long term pacing in sinus node disease: effects of stimulation mode on cardiovascular morbidity and mortality. Am Heart J 1988; 116: 16-22.
11. Kay GN, Ellenbogen KA, Giudici M et al. The Ablate and Pace Trial: a prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation. J Interv Card Electrophysiol 1998; 2: 121-35.
12. Daoud E, Doshi R, Fellows C et al. Ablate and pace with cardiac resynchronization therapy for patients with reduced ejection fraction: Subgroup analysis of PAVE study. Heart Rhythm 2004; 1: S59 (Abstract 181).
13. Bardy GH, Lee KL, Mark DB et al for the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) investigators. Amiodarone or implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-37.
14. Bristow MR, Saxon LA, Boehmer J et al for COMPANION investigators. Cardiac –resynchronization therapy without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350: 2140-50.
15. Cleland JGF, Daubert JC, Erdmann E et al. for CARE-HF Study investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352: 1539-49.
16. Leclerq C, Walker S, Linde C et al. Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation. European Heart J 2002; 23: 1780-1787.
17. Hay I, Melenovsky V, Fetics BJ et al. Short-term effects of righrt-left heart sequential cardiac resynchronization in patients with heart failure, chronic atrial fibrillation, and atrioventricular block. Circulation 2004; 110: 3404-3410.
18. Leon RL, Greenberg JM, Kanuru N et al. Cardiac resynchronization in patients with congestive herat failure and c hronic atrial fibrillation. J Am Coll Cardiol 2002; 39: 1258-1263.
19. Valls-Bertault V, Fatemi M, Gilard M et al. Assessment of upgrading to biventricular pacing in patients with right ventricular pacing and congestive heart failure after atrioventricular junctional ablation for chronic atrial fibrillation. Europace 2004; 6: 438-443.
20. Toubol P. Atrioventricular nodal ablation and pacemaker implantation in patients with atrial fibrillation. Am J Cardiol 1999; 83(5B): 241-245.
21. Morrady F, Hasse C, Stricberger SA et al. Long-term follow-up after radiofrequency modification of atrioventricular mode in patients with atrial fibrillation. J Am Coll Cardiol 1997; 29: 113-121.
22. Proclemer A, DellaBellaP, Tondo C et al. Radiofrequency ablation of atrioventricular junction and pacemaker implantattion versus modulation of atrioventricular conduction in drug refractory atrial fibrillation. Am J Cardiol 199; 83: 1437-1442.
23. Geelen P, Brugada J, Andries E et al. Ventricular fibrillation and sudden cardiac death after radiofrequency catheter ablation of the atrioventricular junction. PACE 1997; 20: 343-348.
24. Čihák R, Heinc P. Doporučení pro léčbu fibrilace síní. Cor Vasa 2004; 46(5K): 67-77.
25. Táborský M, Kautzner J, Bytešník J et al. Zásady pro implantace kardiostimulátorů, implantabilních kardioverterů-defibrilátorů a srdeční resynchronizační léčbu. Cor Vasa 2005; 47: 59-68.
Labels
Paediatric cardiology Internal medicine Cardiac surgery CardiologyArticle was published in
Cardiology Review
2006 Issue Supplementum
Most read in this issue
- Catheter ablation of atrioventricular nodal reentrant tachycardia: therapy of the first choise?
- Catheter-based treatment of common atrial flutter yesterday and today
- Catheter ablation of accessory links: solved question?
- AV node ablation: new aspects in the time of curative therapy of atrial fibrillation and cardiac resynchronization therapy